Treatment of overactive bladder syndrome first requires a clear diagnosis.

Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.

Becky hates flying and spiders, but loves her food and toilets - which could be something to do with overactive bladder syndrome.

The purpose of this systematic review is to compare the benefits and harms of drugs used to treat overactive bladder syndrome.

It is not known whether this selectivity for the M receptor translates into any clinical advantage when treating symptoms of overactive bladder syndrome.

For example, a patient complaining of urinary urgency (or rushing to the toilet), with increased frequency of urination can have overactive bladder syndrome.

Propiverine is an anticholinergic drug used for the treatment of urinary urgency, frequency and urge incontinence, all symptoms of overactive bladder syndrome.

NIH: "Urinary Incontinence in Women," "Comparing Drugs for Overactive Bladder Syndrome."

Solabegron relaxes the bladder smooth muscle by stimulating beta-3 adrenoceptors, a novel mechanism compared to older established drug treatments for overactive bladder syndrome such as the anticholinergic agents.

Pharmacologic treatment for overactive bladder syndrome includes darifenacin, flavoxate hydrochloride, hyoscyamine, oxybutynin chloride, tolterodine tartrate, trospium chloride, scopolamine transdermal, and solifenacin succinate.

In people with overactive bladder syndrome, involuntary bladder contractions lead to frequent and often urgent urination, meaning you have to get to a bathroom right now - even if your bladder is not full.

This one highlights Overactive Bladder syndrome (OAB) - not, it turns out, a kindly euphemism for the failings of old age, but a condition afflicting nearly one in five people over 40.

Fesoterodine (INN, used as the fumarate under the brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome (OAB).